At the end of the latest market close, Atossa Therapeutics Inc. (ATOS) was valued at $2.02. In that particular session, Stock kicked-off at the price of $2.04 while reaching the peak value of $2.08 and lowest value recorded on the day was $2.00. The stock current value is $1.88.
Recently in News on April 8, 2021, Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases, today announced that an ovarian cancer patient has begun treatment with Atossa’s proprietary oral Endoxifen. The FDA previously issued a “Safe to Proceed” letter under their expanded access pathway, permitting the use of Atossa’s oral Endoxifen in this patient. The patient is being treated at the University of Washington Medical Center by Dr. Barbara Goff, Surgeon-in-Chief. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Atossa Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.90 on 02/04/21, with the lowest value was $0.88 for the same time period, recorded on 01/06/21.
Atossa Therapeutics Inc. (ATOS) full year performance was 27.85%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atossa Therapeutics Inc. shares are logging -62.99% during the 52-week period from high price, and 132.10% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.81 and $5.08.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4081472 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Atossa Therapeutics Inc. (ATOS) recorded performance in the market was 112.63%, having the revenues showcasing 112.86% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 244.06M, as it employees total of 4 workers.
Analysts verdict on Atossa Therapeutics Inc. (ATOS)
During the last month, 1 analysts gave the Atossa Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.02, with a change in the price was noted +0.30. In a similar fashion, Atossa Therapeutics Inc. posted a movement of +19.21% for the period of last 100 days, recording 17,234,674 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATOS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Atossa Therapeutics Inc. (ATOS): Technical Analysis
Raw Stochastic average of Atossa Therapeutics Inc. in the period of last 50 days is set at 2.94%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.97%. In the last 20 days, the company’s Stochastic %K was 6.29% and its Stochastic %D was recorded 9.21%.
Let’s take a glance in the erstwhile performances of Atossa Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 112.63%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -13.68%, alongside a boost of 27.85% for the period of the last 12 months. The shares increased approximately by -6.48% in the 7-day charts and went up by -30.58% in the period of the last 30 days. Common stock shares were driven by 112.86% during last recorded quarter.